Article Details
Retrieved on: 2024-11-17 22:30:00
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the BRAIN-AF trial, which explored rivaroxaban's role in preventing cognitive decline in atrial fibrillation patients. Though diabetes was excluded, shared risk factors may link cardiac arrhythmias and brain disorders, informing future research.
Article found on: www.medpagetoday.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here